Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 15.01.2025
SAF-HOLLAND SE
SAF-HOLLAND SE achieves Group sales of EUR 1,877 million according to provisional calculations – adjusted EBIT margin target of around 10% expected to be achieved almost exactly
Bessenbach (Germany), January 15, 2025. Based on provisional calculations, SAF-HOLLAND SE ("SAF-HOLLAND") generated Group sales of approximately EUR 1,877 million in f [ … ]
Wed, 15.01.2025
Laxxon Medical
Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form New York, 01/15/2025 / 09:15, EST/EDT - EQS Newswire - Laxxon Medical
Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the successful res [ … ]
Wed, 15.01.2025
Mynaric AG
MUNICH, January 15, 2025 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced that it received a notification letter dated January 9, 2025 (the “Deficiency Letter I”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasd [ … ]
Wed, 15.01.2025
beaconsmind AG
Publication of Inside Information pursuant to Article 17 of Regulation (EU) No. 596/2014
beaconsmind Group successfully closed the acquisitions of Swissnet AG and Lokalee and completed the set up new Swissnet MENA entities
Wollerau, Switzerland - January 15, 2025 - beaconsmind Group (ISIN: CH0451123589 - Ticker: MLBMD) has successfully closed the [ … ]
Wed, 15.01.2025
SHS Gesellschaft für Beteiligungsmanagement mbH
Healthcare Specialists GENUI and SHS Capital jointly invest in ROTOP, a leading manufacturer and CDMO of radiopharmaceuticals
GENUI and SHS Capital are jointly investing in the German company ROTOP Pharmaka GmbH, a provider of development and manufacturing capacities for radiodiagnostics and radiotherapeutics.
The objective of the growth investm [ … ]
Wed, 15.01.2025
Heliad AG
Berlin, January 15, 2025 – Nelly Solutions, one of Europe’s fastest-growing health and fintech companies, has successfully closed a €50 million Series B funding round. This capital will accelerate the company’s mission to digitalize the European healthcare sector and make administrative and financial processes in medical facilities significantly mo [ … ]
Wed, 15.01.2025
PNE AG
Corporate News
Heiko Wuttke takes over as CEO of PNE AG
Thanks to Per Hornung Pedersen
PNE AG's Board of Management temporarily consists of four members
Cuxhaven, January 15, 2025 – As planned, Heiko Wuttke has taken over the position of CEO of PNE AG. He replaces Per Hornung Pedersen, who had led PNE AG on an interim basis since August 2024.
[ … ]
Wed, 15.01.2025
The Platform Group AG
The Platform Group AG: Capital Markets Day – Invitation
Düsseldorf, 15 January 2025. The Platform Group AG (ISIN DE000A2QEFA1, “TPG“), a leading software company for platform solutions, is pleased to invite investors, analysts and financial media to the Capital Markets Day on 31 January 2025 on-site in Frankfurt/Main and virtually via webcast. The [ … ]
Wed, 15.01.2025
Allane SE
PRESS RELEASEAllane Mobility Group electrifies fleet of major customer and sets standards for sustainable mobility
Pullach, 15 January 2025 – Allane Mobility Group, specialist for vehicle leasing and full-service solutions in Germany, has electrified the service fleet of a renowned major customer. The project was implemented by Allane Fleet in col [ … ]
Wed, 15.01.2025
Goldinvest Consulting GmbH
Canadian biotech company Hemostemix (TSXV:HEM; FRA:2VF0) has confidently secured the registered trademark "your fountain of youth" (TM)[1]"). But what sounds like science fiction or mere marketing is not. Rather, this promise gets to the heart of Hemostemix's stem cell therapy: the company has treated heart patients, patients with diabetic foot and [ … ]